Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC

References

• Banchereau J, Briere F', Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767— 811.
   PubMed Web of Science ®Google Scholar
• Dieu MC, Vanbervliet B, Vicari A et al. Selective recruitment ofimmature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. 7 Exp Med 1998;188:373–86.
   PubMed Web of Science ®Google Scholar
• Sallusto R Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000;177:134 — 40.
   Google Scholar
• Randolph GJ, Beaulieu S, Lebecque S et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998;282:480— 3.
   Google Scholar
• Cella M, Sallusto F', Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10— 6.
   Google Scholar
• Cella M, Scheidegger D, Palmer-Lehmann K et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. 7 Exp Med 1996;184:747— 52.
   Google Scholar
• Schnurr M, Then F', Galambos P et al. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. 7 Immunol 2000;165: 4704— 9.
   Google Scholar
• de Jong EC, Vieira PL, Kalinski P et al. Microbial compoundsselectively induce Thl cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. Immunol 2002;168:1704— 9.
   Google Scholar
• Kiertscher SM, Roth MD. Human CD14± leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. 7 Leukoc Biol 1996;59: 208–18.
   Google Scholar
• Zhou U, Tedder TE CD14± blood monocytes can differentiate into functionally mature CD83± dendritic cells. Proc Natl Acad Sci USA 1996;93:2588–92.
   PubMed Web of Science ®Google Scholar
• Ratta M, Rondelli D, Fortuna A et al. Generation and functionalcharacterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34± cells. Br 7 Haematol 1998;101:756–65.
   PubMed Web of Science ®Google Scholar
• Ramadan G, Schmidt RE, Schubert J. In vitro generation of human CD86± dendritic cells from CD34± haematopoietic progenitors by PMA and in serum-free medium. Clin Exp Immunol 2001;125: 237–44.
   Google Scholar
• Molldrem JJ. Antigen-specific lymphocyte therapies. Cytotherapy2002;4:315–6.
   PubMed Web of Science ®Google Scholar
• Kochenderfer JN, Molldrem JJ. Leukemia vaccines. Curr OncolRep 2001;3:193–200.
   Google Scholar
• Xu S, Koski GK, Faries M et al. Rapid high efficiency sensitization of CD8± T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. 7 Immunol 2003;171:2251–61.
   PubMed Web of Science ®Google Scholar
• Bender A, Sapp M, Schuler G et al. Improved methods for thegeneration of dendritic cells from nonproliferating progenitors in human blood. 7 Immunol Methods 1996;196:121–35.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Kuhn U, Muller G et al. Pro-inflammatory cytokinesand prostaglandins induce maturation of potent immunostimu-latory dendritic cells under fetal calf serum-free conditions. Eur y Immunol 1997;27:3135–42.
   PubMed Web of Science ®Google Scholar
• Thurner B, Roder C, Dieckmann D et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. 7 Immunol Methods 1999;223:1–15.
   PubMed Web of Science ®Google Scholar
• Ho CS, Munster D, Pyke CM et al. Spontaneous generation andsurvival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 2002;99:2897–904.
   PubMed Web of Science ®Google Scholar
• Dauer M, Obermaier B, Herten J et al. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. Immunol 2003;170:4069–76.
   Web of Science ®Google Scholar
• Kurup VP, Xia JQ_, Rickaby DA et al. Aspergillus fumigatus antigenexposure results in pulmonary airway resistance in wild-type but not in IL-4 knockout mice. Clin Immunol 1999;90: 404–10.
   Google Scholar
• Keever-Taylor CA, Margolis D, Konings S et al. Cytomegalo-virus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells. Biol Blood Marrow Transplant 2001;7:247–56.
   Google Scholar
• Emtage PC, Clarke D, Gonzalo-Dagonzo R et al. Generating potent Thl/Tcl T cell adoptive immunotherapy doses using human IL-12: harnessing the immunomodulatory potential of IL-12 without the in vivo-associated toxicity. 7 Immunother 2003;26:97–106.
   PubMed Web of Science ®Google Scholar
• Palucka KA, Taquet N, Sanchez-Chapuis F et al. Dendritic cellsas the terminal stage of monocyte differentiation. 7 Immunol 1998;160:4587–95.
   PubMed Web of Science ®Google Scholar
• Sallusto E Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus inter-leukin 4 and downregulated by tumor necrosis factor alpha. Exp Med 1994;179:1109–18.
   Google Scholar
• Ramadan G, Schmidt RE, Schubert J. VLIgMM transgene expression in DC via a GPI-anchor using a novel retroviral vector induces an in vitro autologous T-cell proliferation restricted to MHC class I molecules. Hematol 7 2003;4:121–31.
   Google Scholar
• Hausser G, Ludewig B, Gelderblom H et al. Monocyte-deriveddendritic cells represent a transient stage of differentiation in the myeloid lineage. Immunobiology 1997;197:534–42.
   PubMed Web of Science ®Google Scholar
• Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781–803.
   PubMed Web of Science ®Google Scholar
• Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin N Am 2002;16: 875–94.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Boeckh M, Carter RA et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hemato-poietic stem cell transplants after nonmyeloablative condition-ing. Blood 2003;102:827–33.
   PubMed Web of Science ®Google Scholar
• Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608–15.
   PubMed Web of Science ®Google Scholar
• Mahfouz T, Anaissie E. Prevention of fungal infections in the immunocompromised host. Curr Opin Investig Drugs 2003;4:974–90.
   PubMedGoogle Scholar
• Cenci E, Mencacci A, Del Sero G et al. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. 7 Infect Dis 1999;180: 1957–68.
   Google Scholar
• Romani L. The T cell response against fungal infections. Curr Opin Immunol 1997;9:484–90.
   PubMed Web of Science ®Google Scholar
• Grazziutti ML, Rex JH, Cowart RE et al. Aspergillus fumigatus conidia induce a Thl-type cytokine response. 7 Infect Dis 1997;176:1579–83.
   PubMed Web of Science ®Google Scholar
• Kurup VP, Shen HD, Vijay H. Immunobiology of fungal allergens. Int Arch Allergy Immunol 2002;129:181–8.
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Boeckh M et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiol-ogy and risk factors. Blood 2002;100:4358–66.
   PubMed Web of Science ®Google Scholar
• Cenci E, Mencacci A, Bacci A et al. T cell vaccination in micewith invasive pulmonary aspergillosis. 7 Immunol 2000;165:381–8.
   PubMed Web of Science ®Google Scholar
• Bozza S, Gaziano R, Lipford GB et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 2002;4:1281–90.
   PubMed Web of Science ®Google Scholar
• Bozza S, Perruccio K, Montagnoli C et al. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 2003;102:3807–14.
   PubMed Web of Science ®Google Scholar
• Kurup VP. Fungal allergens. Curr Allergy Asthma Rep 2003;3:416–23.
   PubMed Web of Science ®Google Scholar
• Banerjee B, Kurup VP, Greenberger PA et al. Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronch- opulmonary aspergillosis (ABPA). Gun Exp Allergy 2001;31:761–70.
   PubMedGoogle Scholar
• Borysiewicz LK, Graham S, Hickling JK et al. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur 7 Immunol 1988;18: 269–75.
   Google Scholar
• Meyers JD, Flournoy N, Thomas ED. Risk factors for cytome-galovirus infection after human marrow transplantation. y Infect Dis 1986;153:478–88.
   Google Scholar
• Winston DJ, Ho WG, Bartoni K et al. Ganciclovir prophylaxis ofcytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann Intern Med 1993;118:179— 84.
   Google Scholar
• Boeckh M, Bowden RA, Gooley T et al. Successful modificationof a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 1999;93:1781–2.
   PubMed Web of Science ®Google Scholar
• Einsele H, Hebart H, Kauffmann-Schneider C et al. Risk factorsfor treatment failures in patients receiving PCR-based pre-emptive therapy for CMV infection. Bone Marrow Transplant 2000;25:757— 63.
   Google Scholar
• Carlsson B, Cheng WS, Totterman TH et al. Ex vivo stimulationof cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators. Br y Haematol 2003;121:428— 38.
   Google Scholar
• Riddell SR, Walter BA, Gilbert MJ et al. Selective reconstitutionof CD8± cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. Bone Marrow Transplant 1994;14 Suppl 4:S78— 84.
   Google Scholar
• Riddell SR, Watanabe KS, Goodrich JM et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238–41.
   PubMed Web of Science ®Google Scholar
• Walter EA, Greenberg PD, Gilbert MJ et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl y Med 1995;333:1038–44.
   PubMed Web of Science ®Google Scholar
• Peggs K, Verfuerth S, Mackinnon S. Induction of cytomegalo-virus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. Blood 2001;97:994— 1000.
   Google Scholar
• Peggs K, Verfuerth S, Pizzey A et al. Characterization of humancytomegalovirus peptide-specific CD8± T-cell repertoire di-versity following in vitro restimulation by antigen-pulsed dendritic cells. Blood 2002;99:213— 23.
   Google Scholar
• Bender A, Bui L, Feldman M, et al. Inactivated influenza virus,when presented on dendritic cells, elicits human CD8± cytolytic T cell responses. y Exp Med 1995;182:1663— 71.
   Google Scholar
• Brossart P, Goldrath A, Butz E et al. Virus-mediated delivery ofantigenic epitopes into dendritic cells as a means to induce CTL. y Immunol 1997;158:3270–6.
   Google Scholar
• Van Gool SW, Vermeiren J, Rafiq K et al. Blocking CD4O-CD154and CD80/CD86-CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Eur 7 Immunol 1999;29: 2367— 75.
   Google Scholar